CTI BioPharma Announces FDA Places Partial Clinical Hold on Pacritinib IND
February 08, 2016 at 05:36 AM EST
CTI BioPharma Corp.(NASDAQ: CTIC) today announced that the Company received written communication from the U.S. Food and Drug ...